Myelodysplastic-Myeloproliferative Diseases [clinicaltrials_resource:3935aeb550de4ad613188d0712169f29]
Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [clinicaltrials:NCT00055653]clinicaltrials:NCT00075816Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant [clinicaltrials:NCT00281814]Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases [clinicaltrials:NCT00813501]Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome [clinicaltrials:NCT02269592]
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00002718Interleukin-2 in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00002746]Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002809]clinicaltrials:NCT00003116Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]clinicaltrials:NCT00003335clinicaltrials:NCT00003336clinicaltrials:NCT00003593clinicaltrials:NCT00003816Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [clinicaltrials:NCT00004058]Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00004245]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004896]Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004899]clinicaltrials:NCT00005622clinicaltrials:NCT00005797Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00005823]Tipifarnib in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00005846]Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00005863]Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia [clinicaltrials:NCT00006040]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [clinicaltrials:NCT00006225]Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006239]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer [clinicaltrials:NCT00006251]clinicaltrials:NCT00006379Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00008164]clinicaltrials:NCT00008216Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT00014235]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00014469]clinicaltrials:NCT00014495MS-275 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00015925]Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer [clinicaltrials:NCT00019656]Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00020969]Bevacizumab in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00022048]Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [clinicaltrials:NCT00025415]clinicaltrials:NCT00027560clinicaltrials:NCT00028730
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00002718Interleukin-2 in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00002746]Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002809]clinicaltrials:NCT00003116Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]clinicaltrials:NCT00003335clinicaltrials:NCT00003336clinicaltrials:NCT00003593clinicaltrials:NCT00003816Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [clinicaltrials:NCT00004058]Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00004245]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004896]Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004899]clinicaltrials:NCT00005622clinicaltrials:NCT00005797Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00005823]Tipifarnib in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00005846]Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00005863]Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia [clinicaltrials:NCT00006040]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [clinicaltrials:NCT00006225]Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006239]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer [clinicaltrials:NCT00006251]clinicaltrials:NCT00006379Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00008164]clinicaltrials:NCT00008216Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT00014235]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00014469]clinicaltrials:NCT00014495MS-275 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00015925]Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer [clinicaltrials:NCT00019656]Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00020969]Bevacizumab in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00022048]Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [clinicaltrials:NCT00025415]clinicaltrials:NCT00027560clinicaltrials:NCT00028730
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Myelodysplastic-Myeloproliferative Diseases [clinicaltrials_resource:3935aeb550de4ad613188d0712169f29]
Bio2RDF identifier
3935aeb550de4ad613188d0712169f29
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3935aeb550de4ad613188d0712169f29
identifier
clinicaltrials_resource:3935aeb550de4ad613188d0712169f29
title
Myelodysplastic-Myeloproliferative Diseases
@en
type
label
Myelodysplastic-Myeloprolifera ...... 5aeb550de4ad613188d0712169f29]
@en
Myelodysplastic-Myeloproliferative Diseases